|
| 37882142 | Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: Insights from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2024 |
| 37634573 | Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction? | J Card Fail | 2024 |
| 36196060 | Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. | Eur J Heart Fail | 2023 |
| 37803813 | Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrum. | ESC Heart Fail | 2023 |
| 37745020 | Changing health related quality of life and outcomes in heart failure by age, sex and subtype. | EClinicalMedicine | 2023 |
| 37649316 | Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry. | ESC Heart Fail | 2023 |
| 37678961 | Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. | JACC Heart Fail | 2023 |
| 37973338 | Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. | Lancet Glob Health | 2023 |
| 37323078 | Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2023 |
| 37317585 | Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2023 |
| 37419495 | Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2023 |
| 37210605 | Patient profiles in heart failure with reduced ejection fraction: Prevalence, characteristics, treatments and outcomes in a real-world heart failure population. | Eur J Heart Fail | 2023 |
| 37076773 | What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II. | Eur Heart J Qual Care Clin Outcomes | 2023 |
| 36974770 | Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. | Eur J Heart Fail | 2023 |
| 37204037 | Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction. | Eur Heart J Cardiovasc Pharmacother | 2023 |
| 37201609 | Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction. | Int J Cardiol | 2023 |
| 36443599 | Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction. | Clin Res Cardiol | 2023 |
| 36718512 | Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry. | Eur Heart J Cardiovasc Pharmacother | 2023 |
| 36781199 | Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2023 |
| 36773746 | Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction. | Am Heart J | 2023 |
| 34486653 | Cardiac resynchronization therapy with or without defibrillator in patients with heart failure. | Europace | 2022 |
| 35550428 | Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population. | J Card Fail | 2022 |
| 35766293 | Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes. | J Am Heart Assoc | 2022 |
| 35502681 | Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality. | Eur J Heart Fail | 2022 |
| 35429091 | Quality of life assessed 6â¿¿months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure). | Eur J Heart Fail | 2022 |
| 35490786 | Sex-related differences among young adults with heart failure in Sweden. | Int J Cardiol | 2022 |
| 35393622 | Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. | Eur Heart J | 2022 |
| 35851740 | Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence. | Eur J Heart Fail | 2022 |
| 35779270 | Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2022 |
| 35654522 | Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry. | JACC Heart Fail | 2022 |
| 35999668 | Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2022 |
| 36175061 | Bereavement and Prognosis in Heart Failure: A Swedish Cohort Study. | JACC Heart Fail | 2022 |
| 36303264 | Association between heart failure quality of care and mortality: a population-based cohort study using nationwide registries. | Eur J Heart Fail | 2022 |
| 36326055 | Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting. | J Am Heart Assoc | 2022 |
| 35257446 | Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2022 |
| 35132793 | Prognostic differences in long-standing vs. recent-onset dilated cardiomyopathy. | ESC Heart Fail | 2022 |
| 34921603 | Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 35278267 | Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata. | Eur J Heart Fail | 2022 |
| 35064730 | Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. | Eur J Heart Fail | 2022 |
| 35170237 | Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure. | ESC Heart Fail | 2022 |
| 34643642 | Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial. | JAMA Cardiol | 2022 |
| 34516969 | A global perspective of racial differences and outcomes in patients presenting with acute heart failure. | Am Heart J | 2022 |
| 32769169 | Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure. | Heart | 2021 |
| 33599357 | Use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2021 |
| 33839078 | Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF. | JACC Heart Fail | 2021 |
| 33779119 | Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction. | Eur J Heart Fail | 2021 |
| 34517016 | Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry. | Int J Cardiol | 2021 |
| 34476878 | Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry. | Eur J Heart Fail | 2021 |
| 34057321 | Prognosis and outcome determinants after heart failure diagnosis in patients who underwent aortic valvular intervention. | ESC Heart Fail | 2021 |
| 34144681 | Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003-2015. | BMC Cardiovasc Disord | 2021 |